PPA
XBI icon

Parametric Portfolio Associates’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Parametric Portfolio Associates’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$22.9M Buy
255,247
+3,706
+1% +$342K 0.01% 873
2021
Q4 		$28.2M Buy
251,541
+246,915
+5,338% +$29.8M 0.01% 776
2021
Q3 		$582K Buy
4,626
+3,081
+199% +$397K ﹤0.01% 3034
2021
Q2 		$209K Sell
1,545
-54
-3% -$7.1K ﹤0.01% 3398
2021
Q1 		$217K Buy
+1,599
New +$239K ﹤0.01% 3845
2020
Q4 		– Sell
-3,224
Closed -$359K – 4034
2020
Q3 		$359K Sell
3,224
-1,668
-34% -$187K ﹤0.01% 3413
2020
Q2 		$548K Buy
+4,892
New +$482K ﹤0.01% 3221
2020
Q1 		– Sell
-2,384
Closed -$227K – 4025
2019
Q4 		$227K Buy
+2,384
New +$206K ﹤0.01% 3692
2019
Q3 		– Sell
-2,542
Closed -$223K – 4003
2019
Q2 		$223K Buy
+2,542
New +$217K ﹤0.01% 3697
2019
Q1 		– Sell
-5,479
Closed -$393K – 3980
2018
Q4 		$393K Buy
5,479
+1,651
+43% +$133K ﹤0.01% 3416
2018
Q3 		$367K Buy
3,828
+106
+3% +$10.3K ﹤0.01% 3554
2018
Q2 		$354K Buy
3,722
+1,247
+50% +$115K ﹤0.01% 3491
2018
Q1 		$217K Sell
2,475
-1,184
-32% -$108K ﹤0.01% 3738
2017
Q4 		$311K Buy
3,659
+606
+20% +$50.8K ﹤0.01% 3553
2017
Q3 		$264K Buy
+3,053
New +$245K ﹤0.01% 3742
2015
Q2 		– Sell
-2,742
Closed -$206K – 4002
2015
Q1 		$206K Buy
+2,742
New +$192K ﹤0.01% 3739
2014
Q3 		– Sell
-27,156
Closed -$1.39M – 3873
2014
Q2 		$1.39M Sell
27,156
-1,536
-5% -$69.3K ﹤0.01% 2423
2014
Q1 		$1.36M Sell
28,692
-2,790
-9% -$143K ﹤0.01% 2390
2013
Q4 		$1.37M Sell
31,482
-546
-2% -$22.6K ﹤0.01% 2400
2013
Q3 		$1.38M Buy
32,028
+4,149
+15% +$168K ﹤0.01% 2282
2013
Q2 		$969K Buy
+27,879
New +$980K ﹤0.01% 2456

Other funds holding XBI

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Parametric Portfolio Associates's XBI Position: Q1 2022 in Review

Parametric Portfolio Associates increased its State Street SPDR S&P Biotech ETF (XBI) stake by 1.5% in Q1 2022, buying an estimated $342K and bringing the position to 255,247 shares worth $22.9M. The position accounts for 0.01% of the portfolio, ranked #873.

Parametric Portfolio Associates first reported a position in XBI in Q2 2013 and has held it in 21 quarters since. The position peaked at $28.2M in Q4 2021. 702 funds tracked by Wall St. Rank hold XBI as of Q1 2022.

  • Parametric Portfolio Associates held 255,247 shares of State Street SPDR S&P Biotech ETF worth $22.9M as of Q1 2022.
  • Parametric Portfolio Associates bought 3,706 State Street SPDR S&P Biotech ETF shares in Q1 2022, an estimated $342K.
  • State Street SPDR S&P Biotech ETF made up 0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #873 holding.
  • Parametric Portfolio Associates first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and has held it in 21 quarters since.
  • Parametric Portfolio Associates's State Street SPDR S&P Biotech ETF position peaked at $28.2M in Q4 2021.
  • 702 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.